학술논문

Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial
Document Type
Letter
Source
In: Journal of the European Academy of Dermatology and Venereology. (Journal of the European Academy of Dermatology and Venereology, October 2023, 37(10):e1211-e1214)
Subject
Language
English
ISSN
14683083
09269959